<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Bevacizumab is a monoclonal antibody against vascular endothelial growth factor </plain></SENT>
<SENT sid="1" pm="."><plain>It is widely used in the treatment of <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>It has some specific side effects including severe <z:mp ids='MP_0001914'>bleeding</z:mp>, wound healing problems, gastrointestinal <z:mpath ids='MPATH_81'>perforation</z:mpath>, <z:hpo ids='HP_0000093'>proteinuria</z:hpo> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>CASE PRESENTATION: We present the case of a 65-year old Asian man with synovial <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of the knee who experienced intraarticular <z:mp ids='MP_0001914'>hemorrhage</z:mp> after bevacizumab treatment </plain></SENT>
<SENT sid="4" pm="."><plain>He presented with <z:e sem="disease" ids="C0158026,C0494905" disease_type="Disease or Syndrome" abbrv="">monoarthritis</z:e> of the left knee </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: Bevacizumab-related <z:mp ids='MP_0001914'>hemorrhage</z:mp> can cause serious morbidity and unusual sites of <z:mp ids='MP_0001914'>hemorrhage</z:mp> may be seen </plain></SENT>
</text></document>